Roivant Sciences CEO Matthew Gline Disposes Shares for Tax Withholding

Executive Summary

On October 20, 2026, Roivant Sciences Ltd. ($ROIV) CEO and Director Matthew Gline filed a Form 4 disclosing a non-derivative transaction executed on October 16, 2026. The transaction involved the disposition of 34,638 Common Shares at a price of $33.53 per share, totaling approximately $1,161,412.14.

Transaction Nature

The transaction was recorded under Code 'F', indicating a net settlement by the issuer to satisfy applicable tax withholding obligations tied to the vesting of performance restricted stock units (PSUs) originally granted on July 26, 2024. These PSUs met both performance-based and service-based vesting conditions. This is a non-discretionary administrative withholding event rather than an open-market sale.

Ownership and Sentiment Impact

Following the withholding, Matthew Gline continues to hold 16,549,136 Common Shares directly. The withheld shares represent only about 0.21% of his overall direct position. Furthermore, the underlying shares issued upon PSU settlement remain subject to a mandatory two-year holding period from the date the service condition was satisfied. Because this disposition was purely to cover tax liabilities associated with equity vesting, it does not indicate any negative shift in executive sentiment.